Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy is promising for hair loss but needs standardized methods and personalization.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Global standardization and stricter regulations are needed for safer herbal hair products and better international trade.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

PRP shows promise for hair growth, but more research and standardized protocols are needed.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

The clinical signs of Adams-Oliver syndrome can vary greatly, even among family members.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Standardized ultrasound methods are needed for measuring scar thickness in clinical practice.

Mesotherapy is a skin injection therapy used for pain and local conditions, with scientific support but needing more clinical trials.

Combining PRP with lipofilling shows promise for tissue regeneration but needs more clinical trials to confirm benefits.

Platelet-rich plasma may improve skin rejuvenation, hair growth, and scar treatment, but more large-scale trials are needed for stronger evidence.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Most ingredients in hair loss shampoos lack strong evidence of effectiveness.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Managing telogen effluvium is challenging due to limited scientific evidence.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Bhrungaraj (Eclipta alba) shows potential for drug development based on its traditional uses and pharmacological evidence.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Restoring NAD⁺ may help with aging and chronic diseases, but more research is needed.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Doctors need to understand statistics to properly evaluate clinical trials for patient care.

Exosomes could improve skin and hair treatments but are limited by cost, production difficulty, and need for more research.

Biotin supplements may improve hair and nail growth in people with certain deficiencies or conditions, but there's not enough evidence to recommend it for healthy individuals.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.